EMCrit Wee – Additional Thoughts on the PREOXI Trial
EMCrit Project
JUNE 15, 2024
more on PREOXI EMCrit Project by Scott Weingart, MD FCCM.
Sat.Jun 15, 2024
106 
New patent expiration for Otsuka drug ABILIFY MYCITE KIT
Drug Patent Watch
JUNE 15, 2024
Annual Drug Patent Expirations for ABILIFY+MYCITE+KIT Abilify Mycite Kit is a drug marketed by Otsuka and is included in one NDA. It is available from one supplier.
Join 11,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Newsletter – June 2024
Fuld & Company Blog
JUNE 15, 2024
This month we focus on helping you sharpen your competitive edge with leading trends in CI and storytelling, and we discuss some of the latest plays we’re seeing in renewable energy. Our upcoming two-part webinar series, “Essential Skills for Competitive Intelligence Professionals” is open to competitive intelligence professionals, market researchers, business analysts, and consultants looking to boost their CI skills.
New patent for Amarin Pharms drug VASCEPA
Drug Patent Watch
JUNE 15, 2024
Annual Drug Patent Expirations for VASCEPA Vascepa is a drug marketed by Amarin Pharms and is included in one NDA. It is available from two suppliers.
Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
A Look at the OBGYN Qualifying Exam Blueprint
Board Vitals - Pharmacist
JUNE 15, 2024
Embarking on a career in obstetrics and gynecology requires a thorough understanding of key topics tested on the OBGYN qualifying examination. This exam is a critical step for aspiring OBGYNs, testing a wide range of skills and knowledge essential to the field. Let’s take a closer look at the content covered on the examination and explore different strategies for preparation.
New patent for Otsuka drug REXULTI
Drug Patent Watch
JUNE 15, 2024
Annual Drug Patent Expirations for REXULTI Rexulti is a drug marketed by Otsuka and is included in one NDA. It is available from two suppliers.
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
More Trending
New patent for Kai Pharms drug PARSABIV
Drug Patent Watch
JUNE 15, 2024
Annual Drug Patent Expirations for PARSABIV Parsabiv is a drug marketed by Kai Pharms Inc and is included in one NDA. It is available from one supplier.
Anthony Fauci says he turned down pharma jobs while he was Covid chief
The Guardian - Pharmaceutical Industry
JUNE 15, 2024
Former infectious disease head says big pharma tried to poach him while he was combating coronavirus Before retiring from his lengthy run as the US government’s top infectious disease doctor, major pharmaceutical companies tried to lure him away from his post by offering him seven-figure jobs – but Anthony Fauci turned them down because he “cared about … the health of the country” too much, he says in a new interview.
New patent for Bausch drug DUOBRII
Drug Patent Watch
JUNE 15, 2024
Annual Drug Patent Expirations for DUOBRII Duobrii is a drug marketed by Bausch and is included in one NDA. It is available from one supplier.
Powering India’s pharmacuetical innovation: The need for an industry-academia collaboration
Express Pharma
JUNE 15, 2024
India, synonymous with the “pharmacy of the world” has rightfully earned the title, owing to its remarkable contribution in supplying 20 per cent of the global generic medicines, along with 60 per cent of the total vaccine demand worldwide. From the Covid-19 pandemic to the floods in Sri Lanka in 2017, India has made significant contributions in assisting several nations, irrespective of geographies – especially in terms of providing low-cost vaccines and other medical aid.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
New patent for Bausch drug BRYHALI
Drug Patent Watch
JUNE 15, 2024
Annual Drug Patent Expirations for BRYHALI Bryhali is a drug marketed by Bausch and is included in one NDA. It is available from one supplier.
Opinion: Readers respond to a plea for rare disease progress, vaccine-related injury, and more
STAT
JUNE 15, 2024
First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.
New patent for Janssen Biotech drug ERLEADA
Drug Patent Watch
JUNE 15, 2024
Annual Drug Patent Expirations for ERLEADA Erleada is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier.
New patent for Janssen Biotech drug BALVERSA
Drug Patent Watch
JUNE 15, 2024
Annual Drug Patent Expirations for BALVERSA Balversa is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier.
Why Every Small Business Needs an HCM Solution: A Comprehensive Guide
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
New patent for Beigene drug BRUKINSA
Drug Patent Watch
JUNE 15, 2024
Annual Drug Patent Expirations for BRUKINSA Brukinsa is a drug marketed by Beigene and is included in one NDA. It is available from one supplier.
New patent for Novartis drug SCEMBLIX
Drug Patent Watch
JUNE 15, 2024
Annual Drug Patent Expirations for SCEMBLIX Scemblix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier.
Which pharmaceutical companies have the most drug patents in New Zealand?
Drug Patent Watch
JUNE 15, 2024
This chart shows the pharmaceutical companies with the most patents in New Zealand.
Let's personalize your content